Physician profile
Joseph C Li
NPI 1144635079
$1,517.15
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $207 · 2021: $389 · 2022: $489.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $471.09 | 2019-2020 | |
| Abbvie INC. | $150.47 | 2021-2022 | |
| Amgen INC. | $142.63 | 2021-2022 | |
| Biogen, INC. | $125.92 | 2019-2022 | |
| Merz North America, INC. | $121.79 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $108.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $81.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $79.42 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $68.12 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.10 | 2022 | |
| Ucb, INC. | $42.35 | 2022 | |
| Celgene Corporation | $20.48 | 2021 | |
| Cranial Technologies, INC | $16.64 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.43 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.68 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.01 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.